Efficacy and safety of rectal misoprostol versus intravenous oxytocin on reducing blood loss in cesarean section: A PRISMA-compliant systematic review and meta-analysis of randomized clinical trials

Blood loss is an inevitable complication and a major contributor to maternal morbidity and mortality at cesarean deliveries. We detected a potential preference regarding the efficacy and safety of rectal misoprostol over oxytocin as a uterotonic agent. We searched PubMed, Scopus, Web of Science, Coc...

Descripción completa

Detalles Bibliográficos
Autores principales: Albazee, Ebraheem, Soliman, Ahmed, Albakri, Khaled, Elbanna, Mohamed, Moussa, Nada Alaa, Faragalla, Hazem Metwally
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236227/
https://www.ncbi.nlm.nih.gov/pubmed/37260225
http://dx.doi.org/10.4274/tjod.galenos.2023.15098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236227/
https://www.ncbi.nlm.nih.gov/pubmed/37260225
http://dx.doi.org/10.4274/tjod.galenos.2023.15098

Ejemplares similares